Healthcare Technology Featured Article

May 20, 2011

Cook Medical signs agreement with Amerinet for PICCS

Cook Medical, a manufacturer of medical devices, recently announced that it has signed an agreement with Amerinet, a nationally recognized health care group purchasing organization for its comprehensive line of peripherally inserted central venous catheters (PICCs). The agreement is effective May 1.

With the agreement with Amerinet, Cook Medical will now provide its PICCs to more than 54,000 health care facilities. Under its range of PICCS, Cook Medical will also provide its Spectrum Turbo-Ject PICC, which is impregnated with the antibiotics minocycline and rifampin and is a critical component in eliminating the 41,000 potentially fatal CRBSIs in the U.S. annually. The broad range of Cook’s PICC products available to Amerinet members also includes silicone PICCs featuring Spectrum technology, Turbo-Flo polyurethane PICCs and the PICC Procedural Tray.

“Amerinet is a leader in advancing the delivery of high-quality health care in an efficient and affordable manner,” said Dan Sirota, vice president and global leader of Cook Medical’s Interventional Radiology division, in a press release. “Cook is proud to continue to be a trusted partner in delivering venous access products to Amerinet’s member facilities. Now more than ever, health care institutions must find ways to prevent dangerous and deadly catheter-related bloodstream infections (CRBSIs). It speaks volumes about the issue of CRBSIs for an organization like Amerinet to adopt the Spectrum technology.”

Cook Medical pioneered many of the medical devices now commonly used to perform minimally invasive medical procedures throughout the body. Today, the company integrates medical devices, drugs and biologic grafts to enhance patient safety and improve clinical outcomes. Recently Cook Medical launched Formula Renal Balloon-Expandable Stent at the Society for Cardiovascular Angioplasty and Intervention (SCAI) 2011 Scientific Sessions. Commercial availability of the Formula follows pre-market approval by the U.S. Food and Drug Administration (FDA) earlier this year for use in patients with atherosclerotic disease of the renal arteries.

Want to learn more about the latest in communications and technology? Then be sure to attend ITEXPO West 2011, taking place Sept. 13-15, 2011, in Austin, Texas. ITEXPO offers an educational program to help corporate decision makers select the right IP-based voice, video, fax and unified communications solutions to improve their operations. It's also where service providers learn how to profitably roll out the services their subscribers are clamoring for – and where resellers can learn about new growth opportunities. To register, click here.

Raju Shanbhag is a contributing editor for HealthTechZone. To read more of Raju’s articles, please visit his columnist page.

Edited by Jamie Epstein
Get stories like this delivered straight to your inbox. [Free eNews Subscription]


FREE eNewsletter

Click here to receive your targeted Healthcare Technology Community eNewsletter.
[Subscribe Now]